GlassScriptPhysician profile
Teresa M Propato
NPI 1306841051
$784.45
in general payments reported to CMS, 2019-2025
14 companies · $308 in 2025
The $308 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.70 · 2020: $71.63 · 2021: $152 · 2022: $62.21 · 2023: $69.32 · 2024: $59.47 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $437.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $163.34 | 2019-2023 | Collagenase Santyl, Stravix Pl, Grafix Pl |
| Inari Medical, INC. | $130.08 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Organogenesis INC. | $113.14 | 2020-2025 | Puraply Wound Matrix |
| Averitas Pharma INC. | $90.24 | 2023-2025 | Qutenza |
| Stryker Corporation | $75.86 | 2021-2025 | Citrefix |
| Zimmer Biomet Holdings, INC. | $73.70 | 2020-2022 | |
| Solventum Corporation | $22.09 | 2025 | Kerramax Care, Promogran Prisma, Activ.A.C. |
| Sandoz INC. | $19.11 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.58 | 2025 | Nuzyra |
| Treace Medical Concepts, INC. | $18.01 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $15.82 | 2021 | |
| Nevro Corp. | $15.50 | 2023 | Senza |
| Kci USA, INC. | $15.29 | 2020 | |
| Acera Surgical, INC. | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Teresa Propato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.